Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • Chapter 16 - Genetics of pediatric multiple sclerosis

  • from Section 3 - Pediatric MS Biology
  • Edited by Dorothée Chabas, University of California, San Francisco, Emmanuelle L. Waubant, University of California, San Francisco
  • Book: Demyelinating Disorders of the Central Nervous System in Childhood
  • Published online: 11 April 2011
  • Print publication: 17 March 2011, pp 169-182

  • Summary

    This chapter discusses the genetics/genetic epidemiology of pediatric multiple sclerosis (MS) as largely derived from information on adults, and draws attention to needed areas of research on pediatric MS, including etiology, pathogenesis, natural history, response to therapy, recovery from relapse, cognition, and activities of daily living. The first direct evidence for a relationship between genes and MS susceptibility came in 1972, when Jersild et al reported an association between human leukocyte antigen (HLA) system alleles and MS. MS is not a monogenic disease and thus recurrence risk data for relatives of patients are based on empiric data rather than strict theoretical models. Recurrence risk data are collected by taking a family history and documenting affected and unaffected statuses among family members of index cases. MS in Northern Europeans has been associated with extended major histocompatibility complex (MHC) haplotypes.